Article (Scientific journals)
Magnitude of Blood Pressure Change After Endovascular Therapy and Outcomes: Insight From the BP-TARGET Trial.
Anadani, Mohammad; Maïer, Benjamin; Escalard, Simon et al.
2022In Stroke, 53 (3), p. 719 - 727
Peer Reviewed verified by ORBi
 

Files


Full Text
anadani-et-al-2022-magnitude-of-blood-pressure-change-after-endovascular-therapy-and-outcomes-insight-from-the-bp.pdf
Author postprint (1.22 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
blood pressure; hemorrhage; mortality; reperfusion; thrombectomy; Aged; Aged, 80 and over; Female; Humans; Male; Reperfusion; Risk Factors; Blood Pressure; Cerebral Hemorrhage/genetics; Cerebral Hemorrhage/physiopathology; Cerebral Hemorrhage/prevention & control; Endovascular Procedures; Stroke/complications; Stroke/physiopathology; Stroke/therapy; Cerebral Hemorrhage; Stroke; Neurology (clinical); Cardiology and Cardiovascular Medicine; Advanced and Specialized Nursing
Abstract :
[en] [en] BACKGROUND AND PURPOSE: To assess the association between systolic blood pressure change (ΔSBP) at different time intervals after successful reperfusion with radiographic and clinical outcomes. METHODS: This is a post hoc analysis of the BP-TARGET multicenter trial (Blood Pressure Target in Acute Stroke to Reduce Hemorrhage After Endovascular Therapy). ΔSBP was defined as end of procedure SBP minus mean SBP at different time intervals (15-60 minutes, 1-6 hours, and 6-24 hours postprocedure). The primary outcome was the poor functional outcome (90-day modified Rankin Scale score 3-6). RESULTS: We included a total of 267 patients (130 in the intensive treatment group). Compared with patients with favorable outcome, patients with poor outcome had lower ΔSBP (less SBP reduction) at all times intervals. After adjusting for potential confounders including baseline SBP, both ΔSBP15-60M and ΔSBP6-24H were associated with lower odds of poor outcome (adjusted odds ratio per 5 mm Hg SBP reduction, 0.89 [95% CI, 0.81-0.99], and adjusted odds ratio 0.82 [95% CI, 0.73-0.92], respectively). Concerning safety outcomes, patients with intraparenchymal hemorrhage had lower ΔSBP at all time intervals. ΔSBP15-60M was associated with lower odds of any intraparenchymal hemorrhage (adjusted odds ratio per 5 mm Hg SBP reduction 0.91 [95% CI, 0.83-0.99]). Conversely, ΔSBP was not associated with mortality or neurological deterioration at any time interval. CONCLUSIONS: After successful reperfusion, ΔSBP had a linear relationship with poor outcome and the risk of poor outcome was higher with less reduction from the baseline SBP. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03160677.
Disciplines :
Neurology
Author, co-author :
Anadani, Mohammad ;  Department of Neurology, Washington University, St Louis, MO (M.A ; Department of Neurosurgery, Medical University of South Carolina, Charleston (M.A
Maïer, Benjamin ;  Department of Interventional Neuroradiology, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France (B.M., S.E., J.-P.D., R.B., M.P., M.M ; University of Paris, France (B.M., J.-P.D., M.M ; FHU Neurovasc, Paris, France (B.M., J.-P.D., R.B., M.P., M.M
Escalard, Simon ;  Department of Interventional Neuroradiology, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France (B.M., S.E., J.-P.D., R.B., M.P., M.M
Labreuche, Julien ;  University of Lille, CHU Lille, ULR 2694-METRICS: Évaluation des technologies de santé et des pratiques médicales, France (J.L ; CHU Lille, Department of Biostatistics, France (J.L
de Havenon, Adam ;  Department of Neurology, University of Utah, Salt Lake City (A.d.H
Sabben, Candice
Lapergue, Bertrand;  Division of Neurology, Department of Neurology, Stroke Centre, Foch Hospital, University Versailles Saint-Quentin en Yvelines, Suresnes, France (B.L
Gory, Benjamin ;  Department of Diagnostic and Therapeutic Neuroradiology, Nancy, France (B.G ; Université de Lorraine, IADI, INSERM U1254, Nancy, France (B.G
Richard, Sebastien 
Sibon, Igor 
Desilles, Jean-Philippe ;  University of Paris, France (B.M., J.-P.D., M.M ; FHU Neurovasc, Paris, France (B.M., J.-P.D., R.B., M.P., M.M
Blanc, Raphael ;  FHU Neurovasc, Paris, France (B.M., J.-P.D., R.B., M.P., M.M
Piotin, Michel ;  FHU Neurovasc, Paris, France (B.M., J.-P.D., R.B., M.P., M.M
Mazighi, Mikael ;  Department of Interventional Neuroradiology, Hôpital Fondation Ophtalmologique Adolphe de Rothschild, Paris, France (B.M., S.E., J.-P.D., R.B., M.P., M.M ; University of Paris, France (B.M., J.-P.D., M.M ; FHU Neurovasc, Paris, France (B.M., J.-P.D., R.B., M.P., M.M
of behalf the BP-TARGET Study Group*
More authors (5 more) Less
Other collaborator :
Delvoye, François  ;  Université de Liège - ULiège > Département des sciences cliniques
Language :
English
Title :
Magnitude of Blood Pressure Change After Endovascular Therapy and Outcomes: Insight From the BP-TARGET Trial.
Publication date :
March 2022
Journal title :
Stroke
ISSN :
0039-2499
eISSN :
1524-4628
Publisher :
Lippincott Williams & Wilkins, United States
Volume :
53
Issue :
3
Pages :
719 - 727
Peer reviewed :
Peer Reviewed verified by ORBi
Funding text :
This work was funded by the French health Ministry, PHRC-IR, AOR16037; BP-TARGET: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03160677.
Available on ORBi :
since 20 January 2025

Statistics


Number of views
33 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
6
Scopus citations®
without self-citations
6
OpenCitations
 
2
OpenAlex citations
 
7

Bibliography


Similar publications



Contact ORBi